ZYDUSLIFE2024-04-012024-06-30 ZYDUSLIFE2024-04-012024-06-30in-bse-fin:OneOperatingExpenses01Member ZYDUSLIFE2024-04-012024-06-30in-bse-fin:OneOperatingExpenses02Member ZYDUSLIFE2024-06-30 ZYDUSLIFE2024-04-012024-06-30in-bse-fin:OneReportableSegmentRevenue01Member ZYDUSLIFE2024-04-012024-06-30in-bse-fin:OneReportableSegmentRevenue02Member ZYDUSLIFE2024-04-012024-06-30in-bse-fin:OneReportableSegmentResults01Member ZYDUSLIFE2024-04-012024-06-30in-bse-fin:OneReportableSegmentResults02Member ZYDUSLIFE2024-04-012024-06-30in-bse-fin:OneReportableSegmentAssets01Member ZYDUSLIFE2024-04-012024-06-30in-bse-fin:OneReportableSegmentAssets02Member ZYDUSLIFE2024-04-012024-06-30in-bse-fin:OneReportableSegmentLiabilities01Member ZYDUSLIFE2024-06-30in-bse-fin:OneReportableSegmentLiabilities01Member ZYDUSLIFE2024-04-012024-06-30in-bse-fin:OneReportableSegmentLiabilities02Member ZYDUSLIFE2024-06-30in-bse-fin:OneReportableSegmentLiabilities02Member ZYDUSLIFE2024-04-012024-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member ZYDUSLIFE2024-04-012024-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss02Member ZYDUSLIFE2024-04-012024-06-30in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 532321 ZYDUSLIFE NOTLISTED Zydus Lifesciences Limited Equity 2024-04-01 2025-03-31 2024-08-09 2024-07-18 INR Millions First quarter 12:00:00 12:40:00 2024-08-09 2024-08-09 Not applicable Multi segment 2024-04-01 2024-06-30 Unaudited Consolidated 62075000000.00 632000000.00 62707000000.00 11155000000.00 5224000000.00 -518000000.00 8835000000.00 322000000.00 2153000000.00 16539000000.00 43710000000.00 18997000000.00 0.00 18997000000.00 6538000000.00 -2177000000.00 4361000000.00 0.00 14636000000.00 0.00 0.00 0.00 189000000.00 14825000000.00 -236000000.00 14589000000.00 14199000000.00 626000000.00 13963000000.00 626000000.00 1006000000.00 1 14.11 14.11 0.00 0.00 14.11 14.11 Net Loss / (Gain) on foreign currency transactions 252000000.00 Other expenses 16287000000.00 Consumer Products 8382000000.00 Pharmaceuticals 53693000000.00 62075000000.00 62075000000.00 Consumer Products 1501000000.00 Pharmaceuticals 17496000000.00 18997000000.00 18997000000.00 Consumer Products 59264000000.00 Pharmaceuticals 245502000000.00 304766000000.00 Consumer Products 4242000000.00 Pharmaceuticals 64915000000.00 69157000000.00 Re-measurement (losses)/ gains on post employment defined benefit plans 3000000.00 Net (loss)/ gain on Fair Value through OCI Equity Securities 98000000.00 101000000.00 2000000.00 Exchange differences on translation of foreign operations -335000000.00 -335000000.00 0.00